Aquestive Therapeutics, Inc. (35) | Business Finance (22)

Browse by Subcategory

Recent Contracts

Form of Securities Purchase Agreement dated June 6, 2022, by and among Aquestive Therapeutics, Inc. and the purchasers (Filed With SEC on June 8, 2022)
Form of Common Stock Warrant (Filed With SEC on June 8, 2022)
Fifth Supplemental Indenture, dated May 13, 2022, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank Trust Company, National... (Filed With SEC on May 17, 2022)
Registration Rights Agreement, dated as of April 12, 2022, by and between the Company and Lincoln Park (Filed With SEC on April 13, 2022)
Waiver Agreement dated as of September 30, 2021, among Aquestive Therapeutics, Inc., at the Noteholder party thereto (Filed With SEC on October 6, 2021)
Amendment No. 1 to the Equity Distribution Agreement, dated March 26, 2021, by and between Aquestive Therapeutics, Inc. and Piper Sandler & Co (Filed With SEC on March 26, 2021)
Form of 2020 Purchase Agreement in connection with the 2020 issuance of 12.5% Senior Secured Notes (Filed With SEC on March 9, 2021)
Aquestive Therapeutics, Inc. Employee Stock Purchase Plan as Amended (Filed With SEC on March 11, 2020)
Underwriting Agreement, dated December 12, 2019, by and between Aquestive Therapeutics, Inc. and BMO Capital Markets Corp., as representative of the several underwriters named... (Filed With SEC on December 16, 2019)
Form of Pre-Funded Warrant (Filed With SEC on June 8, 2022)
Amendment No. 2 to the Purchase Agreement, dated as of May 13, 2022, by and among the Aquestive Therapeutics, Inc. and the Purchasers signatory thereto (Filed With SEC on May 17, 2022)
Purchase Agreement, dated as of April 12, 2022, by and between the Company and Lincoln Park (Filed With SEC on April 13, 2022)
Fourth Supplemental Indenture, dated October 7, 2021, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank, National Association,... (Filed With SEC on October 8, 2021)
Third Supplemental Indenture, dated August 6, 2021, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank, National Association, as... (Filed With SEC on August 9, 2021)
Purchase and Sale Agreement, dated as of November 3, 2020, by and between Aquestive Therapeutics, Inc. and MAM Pangolin Royalty, LLC (Filed With SEC on March 9, 2021)
Second Supplemental Indenture dated November 20, 2020, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank National Association,... (Filed With SEC on March 9, 2021)
First Supplemental Indenture dated November 3, 2020, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank National Association, as... (Filed With SEC on March 9, 2021)
Paycheck Protection Program Promissory Note dated April 17, 2020, between Aquestive Therapeutics, Inc., as Borrower, and Frost Bank, as Lender (Filed With SEC on April 20, 2020)
Form of Warrant (Filed With SEC on July 16, 2019)
Indenture Dated as of July 15, 2019, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank National Association, as Trustee and... (Filed With SEC on July 16, 2019)
Form of Purchase Agreement (Filed With SEC on July 16, 2019)
Aquestive Therapeutics, Inc. Employee Stock Purchase Plan (Filed With SEC on June 18, 2019)